Form 4: Algorhythm Director Receives Equity Awards

Sentiment:

Insider Transaction Report


Algorhythm Holdings Director Harvey Judkowitz was granted 19,532 restricted shares and options to purchase an additional 19,532 shares under the company's 2022 Equity Incentive Plan.

Summary

  • Harvey Judkowitz, a Director of Algorhythm Holdings, Inc. (RIME), received a restricted stock award (RSA) for 19,532 shares of common stock.
  • The RSA was granted on November 20, 2025, with a price of $0, and vests in equal quarterly installments over one year from the grant date.
  • Judkowitz also received a non-qualified stock option to purchase 19,532 shares of the Issuer's common stock.
  • The stock option was granted on November 20, 2025, with an exercise price of $1.28 per share and an expiration date of November 20, 2035.
  • The shares subject to the non-qualified stock option vest and become exercisable in equal quarterly installments over one year from the grant date.
  • Both awards were issued pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies standard compensation practices that align a director's interests with long-term shareholder value, without indicating any immediate operational or financial changes.

Positives

  • The grant of restricted stock and stock options aligns the director's interests with those of shareholders, incentivizing long-term company performance.
  • The use of an established equity incentive plan (2022 Equity Incentive Plan) indicates a structured approach to executive and director compensation.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction, focusing solely on an insider equity transaction.

Industry Context

StockSavvy.ai notes that the granting of equity awards, such as restricted stock and stock options, to directors is a standard practice across various industries. This compensation structure is widely used to attract, retain, and motivate key personnel by linking their financial interests directly to the company's stock performance and long-term success.

Comparison to Industry Standards

  • Equity incentive plans are a common mechanism for compensating directors and executives in publicly traded companies, aligning their interests with shareholders. This practice is consistent with compensation strategies observed in companies like Apple Inc. (AAPL) and Microsoft Corp. (MSFT), which regularly grant restricted stock units and stock options to their leadership.
  • The vesting schedule of one year in quarterly installments is a typical short-to-medium term incentive structure, comparable to many peer companies that aim to retain talent while encouraging sustained performance.
  • The exercise price of $1.28 for the stock options, if at or above the market price on the grant date, is standard for non-qualified options, providing a future upside potential tied to stock appreciation.

Stakeholder Impact

  • Shareholders: The equity awards are intended to align the director's financial interests with shareholder value creation, potentially leading to more focused long-term decision-making.
  • Employees: The use of an equity incentive plan may signal a broader strategy for employee retention and motivation, though this specific filing pertains only to a director.

Next Steps

  • The restricted stock and stock options will vest in equal quarterly installments over a period of one year from the grant date of November 20, 2025.

Key Dates

DateDescription
11/20/2025Date of grant for both the Restricted Stock Award and the Non-Qualified Stock Option.
11/20/2025Start date for the one-year quarterly vesting period for both awards.
11/20/2035Expiration date for the Non-Qualified Stock Option.
03/30/2026Date the Form 4 was signed by Harvey Judkowitz.

Recommendation

hold

This Form 4 filing details a standard equity compensation grant to a director, which is a routine event and does not provide new fundamental information to warrant a change in investment recommendation. While it positively aligns director interests with shareholders, it is not a significant catalyst for immediate stock price movement.

Keywords

Algorhythm Holdings, RIME, Form 4, Insider Transaction, Equity Award, Stock Option, Restricted Stock, Director Compensation, Executive Compensation, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.